By Sen. Tracy Pennycuick 24th District I heard it said recently that it’s great politics to be all things to all people.

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Cash position of €7.5 million as of December 31, 2024 BioChaperone Lispro final dosing of Phase 3 triggered a $10 million revenue recognition, and top-line data are expected in mid-2025 ...

It won’t happen until after the quarterback position is resolved. It might not transpire until late in training camp or a few ...

Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

David Beckham has just launched IM8, an all-in-one supplement that contains 92 vitamins and minerals in one drink. Our beauty ...

Discover everything you need to know about Ruby Slots sister casinos, including exclusive bonuses, games, payments, and ...

The $149 Satechi 6-Port Charging Station can output 200W over multiple USB-C ports, although not as intelligently as the ...

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

The government’s AI Opportunities Action Plan sets out 50 measures intended to transform public services and supercharge the ...